Middle East & Africa Myopia Treatment Market to 2030 - By Size, Share, Growth by End User and Forecast

The Middle East & Africa myopia treatment market was valued at US$ 263.30 million in 2022 and is expected to reach US$ 465.81 million by 2030; it is estimated to register a CAGR of 7.4% from 2022 to 2030.

Application of Artificial Intelligence in Myopia Treatment bolsters Middle East & Africa Myopia Treatment Market

Artificial intelligence (AI) is increasingly being applied in myopia treatment. One example is using AI-powered devices to monitor and analyze eye movements and visual acuity, which can help identify early signs of myopia and track its progression. AI algorithms can also be used to develop personalized patient treatment plans based on their characteristics and medical history. In the future, AI is expected to play an even greater role in myopia treatment. For instance, researchers are exploring the use of machine learning algorithms to predict children who are at high risk of developing myopia, allowing for early intervention and prevention.

Additionally, AI-powered virtual reality systems may improve visual acuity and reduce myopia progression. Thus, the myopia treatment market is expected to see continued growth and innovation in the coming years. With the increasing prevalence of myopia worldwide, there is a growing need for effective and accessible treatments. Advancements in technology, such as AI and advanced surgical techniques, are expected to drive this growth and lead to more personalized and effective treatments for myopia. Additionally, there will likely be a greater focus on preventative measures and collaboration between industry and academia to address this global health concern.

Middle East & Africa Myopia Treatment Market Overview

Middle East & North Africa consists of three major countries: United Arab Emirates (UAE), Saudi Arabia and South Africa. UAE is the largest market for myopia treatment. The market is driven by increasing incidences of eye disorders, growing consumer awareness of myopia, and increasing penetration of international players in the region.

Saudi Arabia has made great strides in improving eye health. As per the WHO, around 8,000 children have functional low vision in Saudi Arabia. Congenital glaucoma is among the leading cause of childhood blindness in the country. Moreover, the increasing use of computers and smartphones creates demand for eye supplements during the forecast period. Prevention of blindness and deafness has been incorporated into Saudi Arabia's new primary health care policy. To maintain a continuum of eye care, a 5-10-year program that encompasses screening for Retinopathy of Prematurity (ROP), preschool vision, diabetic retinopathy, glaucoma, and cataracts is being developed within existing health structures. The MOH is establishing four additional eye centers nationwide to deliver these services. Therefore, the government in the country is implementing campaigns and community-based education programs, which are influential elements for eye health promotion strategies. The strategies help raise awareness and encourage the community to take responsibility for eye health. The action further enforces the appropriate employment of the available eye care services. For instance, the Ministry of Health (MoH) provides educational messages on eye diseases. This helps educate people about glaucoma, myopia, amblyopia, diabetic retinopathy, and contact lenses. Thus, the abovementioned factors are expected to offer lucrative opportunities for the myopia treatment market growth in the coming years.

Middle East & Africa Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

https://www.businessmarketinsights.com/assets/rdimages//middle-east-and-africa-myopia-treatment-market-img1.PNG

Get more information on this report

Middle East & Africa Myopia Treatment Strategic Insights

Strategic insights for the Middle East & Africa Myopia Treatment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/middle-east-and-africa-myopia-treatment-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Myopia Treatment Report Scope

Report Attribute	Details
Market size in 2022	US$ 263.30 Million
Market Size by 2030	US$ 465.81 Million
Global CAGR (2022 - 2030)	7.4%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Type High Myopia Degenerative Myopia Progressive Myopia By Treatment Low-Dose Atropine Eye Drops Contact Lenses Ortho-K Refractive Surgery By End User Hospitals and Clinics Specialty Clinics Refractive Surgery Centers
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Alcon AG Bausch Health Companies Inc Carl Zeiss AG CooperVision Inc Johnson & Johnson Vision Care Inc Nidek Co Ltd

Get more information on this report

Middle East & Africa Myopia Treatment Regional Insights

The geographic scope of the Middle East & Africa Myopia Treatment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

geography/middle-east-and-africa-myopia-treatment-market-geography.webp

Get more information on this report

Middle East & Africa Myopia Treatment Market Segmentation

The Middle East & Africa myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the Middle East & Africa myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Middle East & Africa myopia treatment market share in 2022.

In terms of treatment, the Middle East & Africa myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Middle East & Africa myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the Middle East & Africa myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Middle East & Africa myopia treatment market share in 2022.

Based on end user, the Middle East & Africa myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Middle East & Africa myopia treatment market share in 2022.

Based on country, the Middle East & Africa myopia treatment market is categorized into Saudi Arabia, the UAE, South Africa, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa myopia treatment market share in 2022.

Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, and Nidek Co Ltd are some of the leading companies operating in the Middle East & Africa myopia treatment market.

Identical Market Reports with other Region/Countries